ArticleFrontiers in pharmacology2024

Examining the safety of mirabegron: an analysis of real-world pharmacovigilance data from the US FDA adverse event reporting system (FAERS) database.

Junwei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.